BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 35211965)

  • 21. [What is the real price of SOP and OTC drugs? Pilot study on paracetamol].
    Milozzi F; Di Filippo A; Cangini A; Trotta F
    Epidemiol Prev; 2023; 47(1-2):57-66. PubMed ID: 36727257
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adoption of Cost Effectiveness-Driven Value-Based Formularies in Private Health Insurance from 2010 to 2013.
    Brouwer ED; Basu A; Yeung K
    Pharmacoeconomics; 2019 Oct; 37(10):1287-1300. PubMed ID: 31270747
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Generic drug prices and policy in Australia: room for improvement? a comparative analysis with England.
    Mansfield SJ
    Aust Health Rev; 2014 Feb; 38(1):6-15. PubMed ID: 24480618
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Trends in price for topical corticosteroids from 2017 to 2021 and the opportunity for cost savings identifiable at the point of care: A retrospective cross-sectional study.
    Kwa M; Guttentag A; Chase L; van Meijgaard J; Lim HW
    J Am Acad Dermatol; 2024 Jan; 90(1):74-81. PubMed ID: 37730020
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Do pharmaceutical prices rise anticipating branded competition?
    Ellyson AM; Basu A
    Health Econ; 2021 May; 30(5):1070-1081. PubMed ID: 33684255
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Association Between Market Competition and Prices of Generic Topical Dermatology Drugs.
    Li DG; Joyce C; Mostaghimi A
    JAMA Dermatol; 2018 Dec; 154(12):1441-1446. PubMed ID: 30383117
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Statewide Price Variation for Generic Benign Prostatic Hyperplasia Medications.
    Shah AA; Kumar P; Ogunmola AG; Ayyash O; Yabes JG; Sabik LM; Odisho AY; Bandari J; Macleod LC; Davies BJ; Jacobs BL
    Urology; 2021 Feb; 148():224-229. PubMed ID: 32961225
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Evolution of Supply and Demand in Markets for Generic Drugs.
    Frank RG; McGuire TG; Nason I
    Milbank Q; 2021 Sep; 99(3):828-852. PubMed ID: 34075623
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Cost and price of comparable branded and generic pharmaceuticals.
    Bloom BS; Wierz DJ; Pauly MV
    JAMA; 1986 Nov; 256(18):2523-30. PubMed ID: 3773152
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Services provided by community pharmacies in Wayne County, Michigan: a comparison by ZIP code characteristics.
    Erickson SR; Workman P
    J Am Pharm Assoc (2003); 2014; 54(6):618-24. PubMed ID: 25379982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Reforming the Swedish pharmaceuticals market: consequences for costs per defined daily dose.
    Bergman MA; Granlund D; Rudholm N
    Int J Health Econ Manag; 2016 Sep; 16(3):201-214. PubMed ID: 27878673
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in Retail Prices of Prescription Dermatologic Drugs From 2009 to 2015.
    Rosenberg ME; Rosenberg SP
    JAMA Dermatol; 2016 Feb; 152(2):158-63. PubMed ID: 26606197
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Variability in Price of Generic Antipsychotic Medications at Community Pharmacies.
    Kriz CR; Nelson LA; Venkitachalam L; Allsworth JE; Cheng AL; Sommi RW
    Psychiatr Serv; 2020 Oct; 71(10):1005-1010. PubMed ID: 32576120
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Why are pharmacy acquisition costs and consumer prescription drug price indices apparently diverging?
    Wolff C; Lutter R
    Health Econ; 2020 Dec; 29(12):1721-1727. PubMed ID: 32969080
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The High Cost of Prescription Drugs in the United States: Origins and Prospects for Reform.
    Kesselheim AS; Avorn J; Sarpatwari A
    JAMA; 2016 Aug 23-30; 316(8):858-71. PubMed ID: 27552619
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Endogenous versus exogenous generic reference pricing for pharmaceuticals.
    Antoñanzas F; Juárez-Castelló CA; Rodríguez-Ibeas R
    Int J Health Econ Manag; 2017 Dec; 17(4):413-432. PubMed ID: 28508248
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Patient Awareness of Local Drug Price Variation and the Factors That Influence Pharmacy Choice: A Cross-sectional Survey Study.
    Brodsky SD; Awosika OD; Eleryan MG; Rengifo-Pardo M; Kuang X; Amdur RL; Ehrlich A
    J Drugs Dermatol; 2017 Dec; 16(12):1274-1280. PubMed ID: 29240864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Availability and variation of publicly reported prescription drug prices.
    Kullgren JT; Segel JE; Peterson TA; Fendrick AM; Singh S
    Am J Manag Care; 2017 Jul; 23(7):444-448. PubMed ID: 28817781
    [TBL] [Abstract][Full Text] [Related]  

  • 39. State prescription drug price Web sites: how useful to consumers?
    Tu HT; Corey CG
    Res Brief; 2008 Feb; (1):1-16. PubMed ID: 18494180
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Association of Drug Rebates and Competition With Out-of-Pocket Coinsurance in Medicare Part D, 2014 to 2018.
    Lakdawalla D; Li M
    JAMA Netw Open; 2021 May; 4(5):e219030. PubMed ID: 33950205
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.